DE69841110D1 - Verlängerte cdns, die für sekretierte proteine kodieren - Google Patents

Verlängerte cdns, die für sekretierte proteine kodieren

Info

Publication number
DE69841110D1
DE69841110D1 DE69841110T DE69841110T DE69841110D1 DE 69841110 D1 DE69841110 D1 DE 69841110D1 DE 69841110 T DE69841110 T DE 69841110T DE 69841110 T DE69841110 T DE 69841110T DE 69841110 D1 DE69841110 D1 DE 69841110D1
Authority
DE
Germany
Prior art keywords
secreted proteins
extended
extended cdnas
cdns
code
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69841110T
Other languages
English (en)
Inventor
Lydie Bougueleret
Aymeric Duclert
Milne Edwards Jean-Baptiste Dumas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Biodevelopment SAS
Original Assignee
Serono Genetics Institute SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Genetics Institute SA filed Critical Serono Genetics Institute SA
Application granted granted Critical
Publication of DE69841110D1 publication Critical patent/DE69841110D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE69841110T 1997-12-17 1998-12-17 Verlängerte cdns, die für sekretierte proteine kodieren Expired - Lifetime DE69841110D1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US6995797P 1997-12-17 1997-12-17
US7412198P 1998-02-09 1998-02-09
US8156398P 1998-04-13 1998-04-13
US9611698P 1998-08-10 1998-08-10
PCT/IB1998/002122 WO1999031236A2 (en) 1997-12-17 1998-12-17 EXTENDED cDNAs FOR SECRETED PROTEINS

Publications (1)

Publication Number Publication Date
DE69841110D1 true DE69841110D1 (de) 2009-10-08

Family

ID=27490799

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69841110T Expired - Lifetime DE69841110D1 (de) 1997-12-17 1998-12-17 Verlängerte cdns, die für sekretierte proteine kodieren

Country Status (8)

Country Link
EP (1) EP1037977B1 (de)
JP (1) JP2002508182A (de)
AT (1) ATE440951T1 (de)
AU (1) AU758004B2 (de)
CA (1) CA2311572A1 (de)
DE (1) DE69841110D1 (de)
ES (1) ES2330903T3 (de)
WO (1) WO1999031236A2 (de)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6656480B2 (en) 1996-01-11 2003-12-02 Corixa Corporation Compositions and methods for the treatment and diagnosis of breast cancer
US7241876B2 (en) 1996-01-11 2007-07-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6828431B1 (en) 1999-04-09 2004-12-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
GB9701684D0 (en) 1997-01-28 1997-03-19 Smithkline Beecham Plc Novel compounds
US7202342B1 (en) 1999-11-12 2007-04-10 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6465611B1 (en) 1997-02-25 2002-10-15 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US6395278B1 (en) 1997-02-25 2002-05-28 Corixa Corporation Prostate specific fusion protein compositions
US6800746B2 (en) 1997-02-25 2004-10-05 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6630305B1 (en) 1999-11-12 2003-10-07 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6261562B1 (en) 1997-02-25 2001-07-17 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US7033827B2 (en) 1997-02-25 2006-04-25 Corixa Corporation Prostate-specific polynucleotide compositions
US6613872B1 (en) 1997-02-25 2003-09-02 Corixa Corporation Compounds for immunotherapy of prostate cancer and methods for their use
US7517952B1 (en) 1997-02-25 2009-04-14 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
CN1195851C (zh) 1997-02-25 2005-04-06 科里克萨有限公司 用于前列腺癌免疫疗法的化合物及其用途
US6759515B1 (en) 1997-02-25 2004-07-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6620922B1 (en) 1997-02-25 2003-09-16 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6894146B1 (en) 1997-02-25 2005-05-17 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6943236B2 (en) 1997-02-25 2005-09-13 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US6329505B1 (en) 1997-02-25 2001-12-11 Corixa Corporation Compositions and methods for therapy and diagnosis of prostate cancer
US6818751B1 (en) 1997-08-01 2004-11-16 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US20030185830A1 (en) 1997-02-25 2003-10-02 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
US7057017B2 (en) 1997-04-16 2006-06-06 Millennium Pharmaceuticals, Inc. Human dickkopf-related protein and nucleic acid molecules and uses therefor
US7459524B1 (en) 1997-10-02 2008-12-02 Emergent Product Development Gaithersburg Inc. Chlamydia protein, sequence and uses thereof
US7446181B2 (en) 1998-01-15 2008-11-04 Millennium Pharmaceuticals, Inc. Antibodies that bind human Dickkopf-1 proteins
US6075136A (en) * 1998-02-17 2000-06-13 Incyte Pharmaceuticals, Inc. Prostate-associated serine protease
GB9806095D0 (en) * 1998-03-20 1998-05-20 Smithkline Beecham Biolog Novel compounds
DE19818620A1 (de) * 1998-04-21 1999-10-28 Metagen Gesellschaft Fuer Genomforschung Mbh Menschliche Nukleinsäuresequenzen aus Blase-Normal
EP1071772A2 (de) * 1998-04-24 2001-01-31 Genentech, Inc. Fizz proteine
US7125959B2 (en) * 1998-05-15 2006-10-24 Genentech, Inc. PRO4405 polypeptides
CA2332379A1 (en) * 1998-06-29 2000-01-06 Incyte Pharmaceuticals, Inc. Molecules associated with apoptosis
JP2002522016A (ja) * 1998-07-22 2002-07-23 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 神経内分泌特異的タンパク質に類似したタンパク質、およびそれをコードするｃＤＮＡ
US20030096951A1 (en) 1998-08-14 2003-05-22 Kenneth Jacobs Secreted proteins and polynucleotides encoding them
US6844148B1 (en) 1998-09-24 2005-01-18 Pharmacia & Upjohn Company Alzheimer's disease secretase, APP substrates therefor, and uses therefor
US6699671B1 (en) 1998-09-24 2004-03-02 Pharmacia & Upjohn Company Alzheimer's disease secretase, APP substrates therefor, and uses therefor
KR20070004143A (ko) 1998-09-24 2007-01-05 파마시아 앤드 업존 캄파니 엘엘씨 알츠하이머병 세크레타제
AU767187B2 (en) 1998-11-20 2003-11-06 Fuso Pharmaceutical Industries, Ltd. Novel serine protease BSSP6
US7115410B1 (en) 1999-02-10 2006-10-03 Elan Pharmaceuticals, Inc. β-secretase enzyme compositions and methods
US7456007B1 (en) 1998-12-31 2008-11-25 Elan Pharmaceuticals, Inc. β-secretase enzyme compositions and methods
JP4653318B2 (ja) 1999-02-10 2011-03-16 エラン ファーマシューティカルズ，インコーポレイテッド βセクレターゼ酵素組成物および方法
PT1609863E (pt) 1999-03-23 2009-01-02 Genentech Inc Polipéptidos segregados e transmembranares e ácidos nucleicos que os codificam
JP2002541803A (ja) * 1999-04-09 2002-12-10 コリクサ コーポレイション 乳癌の処置および診断のための組成物ならびに方法
CN1244584A (zh) * 1999-05-14 2000-02-16 北京医科大学 具有免疫细胞趋化和造血刺激活性的趋化因子
JP2003503054A (ja) * 1999-06-24 2003-01-28 財団法人相模中央化学研究所 疎水性ドメインを有するヒトプロテイン及びそれをコードするｄｎａ
KR100543857B1 (ko) * 1999-09-01 2006-01-23 제넨테크, 인크. 혈관신생 및 심혈관형성의 촉진 또는 억제
WO2001023558A2 (en) * 1999-09-28 2001-04-05 Incyte Genomics, Inc. Human secretory molecules
FR2801056B1 (fr) * 1999-11-12 2003-03-28 Commissariat Energie Atomique Proteine presente a la surface des cellules souches hematopoietiques de la lignee lymphoide et des cellules nk, et ses applications
CA2392044A1 (en) * 1999-11-19 2001-05-25 Zymogenetics, Inc. Educational kit and method using colipase-like protein-1
US7514408B1 (en) 1999-12-02 2009-04-07 Elan Pharmaceuticals, Inc. β-secretase enzyme compositions and methods
US7018810B1 (en) * 1999-12-07 2006-03-28 Amgen Inc. Chordin-like molecules and uses thereof
WO2001077152A2 (en) * 2000-04-10 2001-10-18 Zymogenetics, Inc. Mammalian disulfide core protein-4
US20050074754A1 (en) * 2000-04-27 2005-04-07 Shoichi Okubo Novel protein and use thereof
JP2002335964A (ja) * 2000-04-27 2002-11-26 Takeda Chem Ind Ltd 新規タンパク質およびその用途
US7125687B1 (en) * 2000-05-05 2006-10-24 Exelixis, Inc. Presenilin enhancers assays
US7048931B1 (en) 2000-11-09 2006-05-23 Corixa Corporation Compositions and methods for the therapy and diagnosis of prostate cancer
AU2002243512A1 (en) * 2001-01-12 2002-07-24 Lexicon Genetics Incorporated Human protease and polynucleotides encoding the same
CA2439941A1 (en) * 2001-03-06 2002-09-12 Incyte Genomics, Inc. Secreted proteins
US7927597B2 (en) 2001-04-10 2011-04-19 Agensys, Inc. Methods to inhibit cell growth
EP1573024A4 (de) 2001-04-10 2007-08-29 Agensys Inc Nukleinsäuren und diesen entprechende, für die behandlung und den nachweis verschiedener krebserkrankungen geeignete proteine
AU2001286171B2 (en) 2001-05-25 2008-01-10 Serono Genetics Institute S.A. Human CDNAs and proteins and uses thereof
US20030039968A1 (en) * 2001-07-10 2003-02-27 Applera Corporation Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
DE60232742D1 (de) * 2001-10-04 2009-08-06 Immunex Corp Ul16-bindungsprotein 4
US7449548B2 (en) 2001-12-07 2008-11-11 Agensys, Inc. Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer
US7858297B2 (en) 2001-12-18 2010-12-28 Centre National De La Recherche Scientifique Cnrs Chemokine-binding protein and methods of use
DE60234713D1 (de) 2001-12-18 2010-01-21 Endocube Sas Neue mit dem zelltod assoziierte proteine aus der thap familie und par4 verwandte signalwege, die bei der kontrolle von apoptosis involviert sind
WO2003070951A1 (fr) * 2002-02-21 2003-08-28 Japan Science And Technology Agency Gene specifique a l'arteriosclerose et utilisation de ce gene
US7109302B1 (en) 2002-04-01 2006-09-19 Human Genome Sciences, Inc. Antibodies that specifically bind to GMAD
FR2841261B1 (fr) * 2002-06-25 2004-08-27 Univ Pasteur Compositions et methodes pour detecter les pathologies affectant la transmission neuromusculaire
AU2003249883A1 (en) * 2002-07-08 2004-01-23 Genova, Ltd. Secreted polypeptide species associated with cardiovascular disorders
AU2003243151A1 (en) 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
WO2004053059A2 (en) * 2002-12-06 2004-06-24 Pharmacia Corporation Mitoneet polypeptide from mitochondrial membranes, modulators thereof, and methods of using the same
WO2004053060A2 (en) * 2002-12-06 2004-06-24 Pharmacia Corporation ANTISENSE MODULATION OF mitoNEET EXPRESSION
JP2006518193A (ja) * 2003-01-16 2006-08-10 ユニバーシティ オブ バージニア パテント ファウンデーション 精子特異的リゾチーム様タンパク質
WO2005069009A2 (en) * 2004-01-19 2005-07-28 Bayer Healthcare Ag DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH HUMAN STEROID PROGESTIN RECEPTOR BETA (mSR-BETA)
CA2574881C (en) 2004-08-04 2013-01-08 Amgen Inc. Antibodies to dkk-1
WO2006105343A2 (en) * 2005-03-30 2006-10-05 Novartis Vaccines And Diagnostics Inc. Dkkl-i splice product modulators for cancer diagnosis and therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2106386A1 (en) 1991-04-18 1992-10-19 Barbara C. F. Chu Oligodeoxynucleotides and oligonucleotides useful as decoys for proteins which selectively bind to defined dna sequences
FR2675803B1 (fr) 1991-04-25 1996-09-06 Genset Sa Oligonucleotides fermes, antisens et sens et leurs applications.
JP3337748B2 (ja) * 1992-09-25 2002-10-21 財団法人神奈川科学技術アカデミー 完全長ｃＤＮＡの合成方法、その中間体の製造方法及び完全長ｃＤＮＡを含む組換えベクターの製造方法
FR2733762B1 (fr) * 1995-05-02 1997-08-01 Genset Sa Methode de couplage specifique de la coiffe de l'extremite 5' d'un fragment d'arnm et preparation d'arnm et d'adnc complet
US5654150A (en) 1995-06-07 1997-08-05 President And Fellows Of Harvard College Method of expression cloning
US5707829A (en) * 1995-08-11 1998-01-13 Genetics Institute, Inc. DNA sequences and secreted proteins encoded thereby
DK1378571T3 (da) * 1997-08-01 2011-04-04 Merck Serono Biodevelopment 5' ESTs for sekreterede proteiner udtrykt i forskellige væv

Also Published As

Publication number Publication date
WO1999031236A3 (en) 1999-09-10
CA2311572A1 (en) 1999-06-24
JP2002508182A (ja) 2002-03-19
WO1999031236A2 (en) 1999-06-24
ATE440951T1 (de) 2009-09-15
ES2330903T3 (es) 2009-12-16
EP1037977A2 (de) 2000-09-27
AU758004B2 (en) 2003-03-13
AU1503099A (en) 1999-07-05
EP1037977B1 (de) 2009-08-26

Similar Documents

Publication Publication Date Title
DE69841110D1 (de) Verlängerte cdns, die für sekretierte proteine kodieren
WO1999025825A3 (en) EXTENDED cDNAs FOR SECRETED PROTEINS
ATE338117T1 (de) 5' ests für proteine, die nicht gewebespezifisch sind
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
WO2002014358A3 (en) Novel secreted proteins and their uses
MXPA02002384A (es) Polipeptidos similares al factor de crecimiento de fibroblastos.
MXPA05010830A (es) Metodos de tratamiento que usan agentes de enlace especificos de angiopoyetina-2 humana.
MXPA02012743A (es) Moleculas tipo il-17 y usos de las mismas.
EP1067182A3 (de) Sekretorische- oder Membranproteine
MXPA02011656A (es) Moleculas de acido nucleico nrg-2, polipeptidos, y metodos de diagnostico y terapeuticos.
NZ502392A (en) Interleukin-18 binding proteins (IL-18BP) their preparation and use in pharmaceuticals
CY1105398T1 (el) 5΄ ESTs ΓΙΑ ΕΚΚΡΙΤΙΚΕΣ ΠΡΩΤΕΪΝΕΣ ΠΟΥ ΕΚΦΡΑΖΟΝΤΑΙ ΣΕ ΔΙΑΦΟΡΟΥΣ ΙΣΤΟΥΣ
ATE418563T1 (de) Nik proteine, nukleinsäure sowie verfahren
DE69837761D1 (de) 5' ests für sekretierte proteine aus gehirngeweben
DE3856180D1 (de) Nukleinsaürefragmente, die mannose bindende fragmente vom menschlichen mannosebindenden protein kodieren
WO2001000806A3 (en) Dna's encoding proteins with signal peptides
WO2002008277A3 (en) Nucleic acids, vectors, host cells, polypeptides, and uses thereof
ATE450603T1 (de) Polypeptide mit verzweigungsenzym-aktivität und für diese kodierende nukleinsäuren
DK1082423T3 (da) Cyclin E2-gener og -proteiner
WO1999054447A3 (de) Menschliche nukleinsäuresequenzen aus blasentumorgewebe
WO2002032939A3 (en) Secreted proteins and their uses
ATE550345T1 (de) Sfrp, mit sfrp-interagierende peptidmotive sowie verwendungsverfahren
DK0939769T3 (da) Vertebrat-Smoothened-proteiner
PL374550A1 (en) Il-17 like molecules and uses thereof
ATE340263T1 (de) Dna-sequenzen, die für die menschliche proteine tx und ty kodieren, die ice gleichen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition